Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses
This study has been completed.
Sponsor:
Children's Research Institute
Collaborator:
Actelion
Information provided by:
Children's Research Institute
ClinicalTrials.gov Identifier:
NCT00672022
First received: May 2, 2008
Last updated: May 5, 2008
Last verified: July 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2007 |
| Primary Completion Date: | August 2007 (Final data collection date for primary outcome measure) |